Annual Revenue
$43.05B$2.96B+7.38%
Summary
- Current Value
- As of today, GSK annual revenue is $43.05B, up +7.38% on
- Historical Performance
- GSK annual revenue is up +19.19% over the past 3 years, down -1.54% over the past 5 years
- All-Time High Comparison
- GSK annual revenue is currently -5.30% below its historical high of $45.46B set on
- 3-Year Low Comparison
- GSK annual revenue is +19.19% above its 3-year low of $36.12B reached on an earlier date
- Sector Comparison
- GSK annual revenue is higher than 97.96% of companies in Healthcare sector
- Upcoming Earnings
- The next annual earnings release for GSK is on
Revenue Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| Quarterly Revenue | $11.94B | +3.6% | +15.8% | +30.8% | +4.5% | |
| TTM Revenue | $44.97B | +6.9% | +23.6% | +15.1% | +1.6% | |
| Price | $50.33 | +6.9% | +44.7% | +13.5% | +11.1% | |
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| PE Ratio | 17.54 | +30.6% | +83.5% | +16.2% | +1.9% | |
| Annual Gross Profit | $30.76B | +9.9% | +28.3% | +3.8% | -3.6% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual EBITDA | $14.43B | +37.5% | +32.7% | +6.8% | +40.3% | |
| Annual EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $43.05B | at high | |
| 5Y | $43.73B | N/A | -1.5% |
| All | $45.46B | -5.3% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $36.12B | N/A | +19.2% |
| 5Y | $33.96B | +26.8% | |
| All | $1.33B | +3138.7% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $37.70B | - | |
| - | $40.09B | - | |
| - | $43.05B | - |
🔒 Log In To Unlock Full Data
Revenue History
FAQ
- What is the current annual revenue of GSK?
- As of today, GSK annual revenue is $43.05B
- What is 1-year change in GSK annual revenue?
- GSK annual revenue is up +7.38% year-over-year
- What is 3-year change in GSK annual revenue?
- GSK annual revenue is up +19.19% over the past 3 years
- How far is GSK annual revenue from its all-time high?
- GSK annual revenue is currently -5.30% below its historical high of $45.46B set on December 31, 2007
- How does GSK annual revenue rank versus sector peers?
- GSK annual revenue is higher than 97.96% of companies in Healthcare sector
- When is GSK next annual earnings release?
- The next annual earnings release for GSK is on
Quarterly Revenue
$11.94B$657.13M+5.82%
Summary
- Current Value
- As of today, GSK quarterly revenue is $11.94B, up +5.82% on
- Historical Performance
- GSK quarterly revenue is up +3.62% year-over-year, up +15.85% over the past 3 years
- All-Time High Comparison
- GSK quarterly revenue is currently -9.73% below its historical high of $13.23B set on
- 3-Year Low Comparison
- GSK quarterly revenue is +27.94% above its 3-year low of $9.34B reached on
- Sector Comparison
- GSK quarterly revenue is higher than 98.00% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $11.94B | +5.8% | +3.6% | +15.8% | +30.8% | |
| Annual Revenue | $43.05B | – | +7.4% | +19.2% | -1.5% | |
| TTM Revenue | $44.97B | +0.9% | +6.9% | +23.6% | +15.1% | |
| Price | $50.33 | -3.5% | +6.9% | +44.7% | +13.5% | |
| Quarterly EPS | $1.02 | +254.2% | -23.1% | +13.0% | +28.3% | |
| PE Ratio | 17.54 | +6.7% | +30.6% | +83.5% | +16.2% | |
| Quarterly Gross Profit | $8.89B | +5.0% | +4.5% | +19.4% | +38.6% | |
| Quarterly Net Income | $2.29B | +208.4% | -20.8% | +17.9% | +75.6% | |
| Quarterly EBIT | $3.45B | +7.3% | -0.4% | +21.6% | +55.4% | |
| Quarterly EBITDA | $4.45B | +26.4% | -0.3% | +24.5% | +28.0% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.94B | at high | |
| 3Y | $11.94B | at high | |
| 5Y | $11.94B | at high | |
| All | $13.23B | -9.7% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.28B | +16.2% | |
| 3Y | $9.34B | +27.9% | |
| 5Y | $8.45B | +41.4% | |
| All | $454.71M | +2526.7% |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $11.46B | - | |
| - | $10.28B | - | |
| - | $11.29B | - | |
| - | $11.94B | - |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
- What is the current quarterly revenue of GSK?
- As of today, GSK quarterly revenue is $11.94B
- What is GSK quarterly revenue most recent change?
- GSK quarterly revenue was up +5.82% on September 30, 2026
- What is 1-year change in GSK quarterly revenue?
- GSK quarterly revenue is up +3.62% year-over-year
- How far is GSK quarterly revenue from its all-time high?
- GSK quarterly revenue is currently -9.73% below its historical high of $13.23B set on December 31, 2009
- How does GSK quarterly revenue rank versus sector peers?
- GSK quarterly revenue is higher than 98.00% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
TTM Revenue
$44.97B$417.27M+0.94%
Summary
- Current Value
- As of today, GSK TTM revenue is $44.97B, up +0.94% on
- Historical Performance
- GSK TTM revenue is up +6.93% year-over-year, up +23.57% over the past 3 years
- All-Time High Comparison
- GSK TTM revenue is currently -3.00% below its historical high of $46.36B set on
- 3-Year Low Comparison
- GSK TTM revenue is +23.57% above its 3-year low of $36.39B reached on an earlier date
- Sector Comparison
- GSK TTM revenue is higher than 98.10% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $44.97B | +0.9% | +6.9% | +23.6% | +15.1% | |
| Annual Revenue | $43.05B | – | +7.4% | +19.2% | -1.5% | |
| Quarterly Revenue | $11.94B | +5.8% | +3.6% | +15.8% | +30.8% | |
| Price | $50.33 | -3.5% | +6.9% | +44.7% | +13.5% | |
| TTM EPS | $2.87 | -9.6% | -18.2% | -21.1% | -2.3% | |
| PE Ratio | 17.54 | +6.7% | +30.6% | +83.5% | +16.2% | |
| TTM Gross Profit | $33.04B | +1.2% | +8.4% | +25.9% | +23.8% | |
| TTM Net Income | $6.48B | -8.5% | -18.7% | -19.2% | +9.3% | |
| TTM EBITDA | $14.10B | -0.1% | -6.8% | +37.3% | +18.3% | |
| TTM EBIT | $11.12B | -0.1% | +6.4% | +35.9% | +36.6% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $44.97B | at high | |
| 3Y | $44.97B | at high | |
| 5Y | $44.97B | at high | |
| All | $46.36B | -3.0% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $42.06B | N/A | +6.9% |
| 3Y | $36.39B | N/A | +23.6% |
| 5Y | $35.00B | +28.5% | |
| All | $540.44M | +8221.2% |
TTM Revenue History
FAQ
- What is the current TTM revenue of GSK?
- As of today, GSK TTM revenue is $44.97B
- What is GSK TTM revenue most recent change?
- GSK TTM revenue was up +0.94% on September 30, 2026
- What is 1-year change in GSK TTM revenue?
- GSK TTM revenue is up +6.93% year-over-year
- How far is GSK TTM revenue from its all-time high?
- GSK TTM revenue is currently -3.00% below its historical high of $46.36B set on March 31, 2010
- How does GSK TTM revenue rank versus sector peers?
- GSK TTM revenue is higher than 98.10% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk